TAGC is a partner of the newly awarded RiPCoN project "Rapid interaction profiling of 2019 nCoV for network based deep drug repurpose learning" that started on April 1st, 2020.
This 3-years project led the Helmholtz Zentrum, Munchen, Germany (Prof. Falter-Braun), to which participates the IRB, Barcelona, Spain (Prof. Aloy), and TAGC (Drs. C. Brun/A. Zanzoni) aims at the identification of approved drugs that can be repurposed for the treatment of SARS-CoV-2 using interactome-profiling and deep-learning.
All the selected projects are detailed in a PDF document of the European Commission : ec_rtd_cv-projects.pdf